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INTRODUCTION  
 
It was almost noon on Friday, October 2, 1987 and the morning chill in lower Manhattan had 
been replaced by a mild breeze, the last breath of summer. Exiting the New York City Public 
Health Building, three companions passed through the grand entrance and descended a short 
flight of steps between massive stone and bronze urns. To the casual observer, they would seem 
an unlikely trio—a multi-millionaire widow heiress, a renowned physician and biomedical 
researcher, and a leader in the anti-war movement turned foundation executive. 
Scanning oncoming Center Street while waiting for Mrs. Diamond‟s car, Vincent McGee, 
executive director of The Aaron Diamond Foundation, shaded his eyes against the sun high in 
the southern sky. Behind him, Dr. Lewis Thomas, a member of the foundation‟s board of 
directors and advisor on medical research, was the first to speak. “Well, what do you think, 
Irene?” 
“I liked Steve Joseph, but wouldn‟t we be getting involved with real bureaucracy!” 
replied Irene Diamond, whose late husband Aaron Diamond left a real estate fortune of nearly 
$400 million, divided evenly between Mrs. Diamond and the foundation. Minutes earlier, New 
York‟s public health commissioner had asked the trio to convene and coordinate a consortium of 
philanthropic foundations to finance a centralized research effort concentrated on the basic 
science of the AIDS virus. Commissioner Joseph said that it was time to bring New York closer 
to its level of responsibility as the epicenter of the emerging AIDS epidemic in the United States. 
He had turned to the fledgling Aaron Diamond Foundation to lead the effort to secure the 
necessary funding from a broad spectrum of donors. 
 The soft-spoken doctor turned to McGee. “Well, what do you think, Vinny?” Before 
McGee could respond, Mrs. Diamond insisted, “Besides, isn‟t bringing together a bunch of other 
foundations going to delay things too long? Just think . . . we‟ll be stuck in meeting after 
meeting!” 
 As Vincent McGee reflected upon the morning‟s events, he wondered whether this young 
foundation that had just emerged from two years of internal power struggles could take on such a 
monumental challenge. Was this a good fit for The Aaron Diamond Foundation? Certainly the 
establishment of a cutting-edge AIDS research laboratory in New York was critical to the 
ongoing battle against the tragic disease. However, since the philanthropic community had not 
yet recognized the need to fund basic research on AIDS, McGee wondered how many other 
foundations would be willing to come along. Moreover, he wondered whether Mrs. Diamond and 
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the still-evolving board of directors would have the patience to build a coalition of foundations 
and to partner with the city government on such an effort. Uncharacteristic of most foundations, 
The Aaron Diamond Foundation had only nine years left to spend down its assets. Would not 
this collaborative effort take many years to plan and launch? Was there another way to ensure the 
successful launch of this endeavor so vital to the fight against AIDS? 
 
 
IRENE DIAMOND: A REAL SCRAPPER 
 
The legendary writer and broadcaster Louis “Studs” Terkel once grinned at Irene Diamond and 
declared, “Wait a minute lady, before I shake your hand, I just need to say that you are a 
scrapper! I like that!”1 At the age of 77, Irene Diamond was as feisty and determined as ever. 
Barely five feet tall and always impeccably dressed, she had bright blue eyes and curly snow 
white hair, which the millionairess cut at home in order to save time and expense. An animated 
conversationalist, Mrs. Diamond was impatient with too many details and was quick to express 
her opinions with great conviction. As she liked to point out, forty years in the “picture business” 
in Hollywood and New York had trained her to cut to the chase. 
 Born to Russian immigrant parents in Pittsburgh in May of 1910, Irene Levine grew 
bored with public school and piano lessons, and she dreamed of one day becoming an actress. 
Changing her name to “Irene Lee” in the early 1920s, she moved to New York with a scholarship 
to study the theater. In 1933, she traveled across the country for her first Hollywood screen test. 
Without acting work, Irene became a story editor for the legendary Samuel Goldwyn at MGM, 
first in Hollywood and then back in New York. In 1941, Irene agreed to run the New York office 
of Hal Wallis, who had left the helm of Warner Brothers to start an independent company. 
 Mrs. Diamond would later assert that the competitive business of being a story editor and 
talent scout during Hollywood‟s golden years prepared her for her work as a philanthropist 
reviewing funding proposals. In a sometimes rocky professional alliance with Wallis that would 
last until 1970, Irene reviewed hundreds of scripts and story ideas—it was up to her to find good 
property and see that it was made into movies. Purchasing more than 30 scripts over the years, 
she wielded considerable power and furthered the careers of Bette Davis, Burt Lancaster, Kirk 
Douglass and Robert Redford. Her most famous discovery was a script entitled “Everybody 
Comes to Rick‟s,” an unproduced play that had already been rejected by several studios. 
Confident that the tough but idealistic title character was the perfect romantic hero for the 
turbulent world of the day, Irene fought for the script with characteristic tenacity. Despite his 
predictions of disaster, the skeptical Wallis finally agreed to purchase the script for $20,000. 
Wallis produced the film and released it in November 1942 under the new title Casablanca.
2
 
Although the movie was a box-office hit and won three Academy Awards, including Best 
Picture, Irene never received a bonus or any public credit from Wallis for her part in the deal. 
 
Marriage to Aaron Diamond 
 Around the time that Irene finished her work on Casablanca, an old friend from her years 
of studying theater introduced Irene to a somewhat shy, good-natured gentleman by the name of 
Aaron Diamond. 
 Born in 1910 in Tennessee, Aaron Diamond was one of nine children. After graduating 
from the University of Chattanooga, he received a scholarship to study at Harvard Business 
School. Graduating with his MBA at the height of the Depression, Aaron was fortunate to be 
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hired by Abraham and Straus department store in New York earning twenty-five dollars week. 
When the country went to war, Diamond joined the Navy. Two days after enlisting, he was 
introduced to Irene (Levine) Lee. On their first date, the smitten Diamond knew that he had met 
the love of his life and he boldly asked Irene to marry him. Seven dates later, Irene finally agreed 
and they were married in 1942. 
 While stationed on Staten Island, Aaron Diamond bought two small hotels in Baltimore 
and Brooklyn Heights. One week after daughter Jean was born in 1944, Diamond was deployed 
to the Philippines for nearly two years. By the time he was discharged from the Navy, his hotels 
had provided a modest nest egg for the young family.  
 Upon his return to New York, Diamond rejected opportunities to work as a salesman and 
instead went into the real estate business with a friend. The partners first built homes in suburban 
New York and then apartments and office buildings in the city. Eventually, Diamond went into 
business for himself and built high rise office buildings in midtown Manhattan and redeveloped 
Roosevelt Island, gaining a reputation as a thoughtful, creative businessman and a man of 
integrity. Feeling deeply about the need to help African Americans migrating from the South in 
search of work, Aaron Diamond was one of the first to build a racially integrated and minority 
managed apartment house in New Rochelle.  
 Despite the Diamonds‟ growing wealth, the couple lived simply and Irene continued in 
her career as a story editor. “My husband was extremely supportive. We had a particularly 
wonderful marriage. We were very, very close, and we both had interests… We changed each 
other a lot. He gave me a much better education about reality in the world, and I got him 
interested in classical music and the ballet. And we both enjoyed what the other had to give very, 
very much. . . . He was interested in the world. We traveled enormously. . . . He was always very 
interested. He was very generous—extremely sensitive to other people.”3 
 
 
THE AARON DIAMOND FOUNDATION 
 
In 1955, the couple established the Aaron Diamond Foundation, intending for the foundation to 
receive the bulk of Mr. Diamond‟s considerable fortune upon his eventual death. In December of 
that year, the Foundation was officially incorporated and the board of directors held its first 
meeting to ratify its articles of incorporation and purpose statement (see Exhibit 1), approve its 
bylaws and corporate seal, fix its office, and authorize the establishment of a bank account. As 
president and treasurer, Mr. Diamond made his first gift of stock to the Foundation, which was 
sold for $15,582.
4
 For the next three decades, the Foundation remained largely inactive, except 
for occasional donations of stock by Mr. Diamond and the minimum activity required of the 
board of directors, which usually numbered between four and six members. During these years, 
the Foundation also served as the vehicle for the modest personal giving of the Diamonds.  
 In the winter and spring of 1984, satisfied that their fortune had grown sufficiently large, 
the Diamonds began making plans to activate the Foundation. “My husband was quite an 
extraordinary man. . . . He loved New York, and he felt it had treated him very well, and he 
wasn‟t really interested in accumulating more and more money.”5 
 While on a long vacation in Florida, the Diamonds sketched out a broad strategy for the 
Foundation. The couple agreed that the focus of the Foundation‟s giving would be New York 
City, where they had spent most of their professional lives. Further, they decided that the 
                                                 
3
 Mariette J. Bates, An American Phenomenon: A Qualitative Study of a Metropolitan Foundation with a Ten Year 
Life Span, Dissertation, The Union Institute, 1995, p. 36. 
4
 Ibid, p. 53. 
5
 Ibid, p. 28 
The Aaron Diamond Foundation: AIDS Research in New York Cityp. 4 
Foundation would divide its giving into three programmatic areas: medical research, minority 
education, and culture, with total giving weighted forty percent in each of the first two areas and 
twenty percent in the third. Lastly, hoping to have as big an impact as possible within a short 
length time, Mr. Diamond determined that the Foundation should spend down its assets within 
ten years of activation, during which time his business should be liquidated and divided evenly 
between his heirs and the Foundation. “We both had a feeling that, if we stuck with our priorities 
and really hit hard with the money, we would probably be able to make a difference,” Mrs. 
Diamond later observed.
6
 Upon their return to New York, the couple met with their attorney, 
who recorded these directions in a letter drawn up in parallel with Mr. Diamond‟s will.7  
 A few weeks later, Aaron Diamond died suddenly of a heart attack at the age of 74. 
Though he enjoyed remarkable health as a young man, Diamond had suffered a heart attack 
seven years earlier, unable to escape the heart disease that ran in his family.  
 In the months following Aaron Diamond‟s sudden death, the grieving Irene Diamond 
depended greatly upon several of her husband‟s business associates and professional advisors to 
care for matters of his estate, which was then worth nearly $380 million.
8
 In accordance with his 
will, it was determined that one half of Mr. Diamond‟s estate would go to the Aaron Diamond 
Foundation, and one half would go to a marital trust in favor of Irene Diamond for her personal 
use during the remainder of her life. The three executors of the estate were also to serve as the 
trustees of Mrs. Diamond‟s trust and as members of the Foundation‟s board of directors.  
 On June 21, 1984, the surviving members of the Foundation‟s board met for the first time 
following Mr. Diamond‟s death. At that meeting, Mrs. Diamond, as the new president of the 
Foundation, reaffirmed the three primary goal areas established by the couple earlier that year, 
and she noted a particular interest in heart disease. Over the next several months, the board 
realized that they would need professional help in activating the Foundation. At the October 2, 
1984 board meeting, Mrs. Diamond agreed to seek qualified personnel to assist in the 
organization of the Foundation.
9
  
 
Vincent McGee Becomes Executive Director 
 With the exception of Mrs. Diamond herself, nobody had a greater influence on the 
Aaron Diamond Foundation than Vincent McGee, a social justice activist turned philanthropy 
professional. As a leader in the anti-war movement of the 1960s, McGee burned his draft card 
and spent a year in federal prison as a conscientious objector, appearing on President Richard 
Nixon‟s infamous “Enemies List.” McGee was later pardoned by President Gerald Ford.10 
 Shortly after his release from prison, Mr. and Mrs. W.H. Ferry hired McGee as the 
executive director of the DJB Foundation, which funded progressive social change and political 
causes. McGee‟s work with the Ferrys had a major influence on his career and on the style of 
grantmaking and operations that he eventually installed at the Aaron Diamond Foundation. “[The 
Ferrys] provided for me an intensive period of learning public interest progressive philanthropy. . 
. . It was a streamlined operation. . . . There was a sense of responsibility about dealing with 
money as a trust and to be responsible to that public trust. You didn‟t take people for granted, 
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you responded in a clear way. If you had questions, you make them succinct and didn‟t make 
people jump through hoops. And you didn‟t keep them waiting.”11  
 McGee later held various positions in the nonprofit sector, including stints with the 
American Civil Liberties Union, the New World Foundation, and the Field Foundation, and he 
served as a vice president of City College of the City University of New York (CUNY). As the 
first executive director of the Hunt Alternatives Fund, McGee helped to develop a grantmaking 
program focusing on community-based support for innovative social change projects in Dallas, 
Denver, and New York. He was on the boards of several human rights and peace organizations, 
serving as the chair of the board of Amnesty International of the U.S.A. in the early 1980s. 
 In the fall of 1984, after McGee had been introduced by an attorney who knew him from 
Amnesty International, the Aaron Diamond Foundation board met with him and, on Mrs. 
Diamond‟s motion, offered him a six-month contract to consult on the development of program 
policies and guidelines for the creation of an organizational plan, and to evaluate funding 
proposals received.
12
  
 
The Struggle for the “Soul” of the Foundation13 
 McGee quickly discovered that he had stepped into a hornets‟ nest. In a follow-up 
meeting with board members other than Mrs. Diamond, it was explained to McGee that the 
Diamonds “had asked that the Foundation have a focus on New York City and medical research, 
minority education, and culture, forty percent for the first two things, twenty percent for culture, 
and that the foundation have a life of ten years.” But, he was told, “of course we‟re not going to 
pay attention to that.”14  
 It was soon obvious to McGee that their intention was to keep Mrs. Diamond on the 
sidelines while the others called the shots. “They actually said to me at one point, „Well, Mrs. 
Diamond is going to participate from a distance and we‟ll keep her happy, but this is going to be 
a very big foundation and there‟s a lot of interesting things that we will do with it.‟”15 
 Dazzled by the great fortune placed seemingly at their discretion, these men whom had 
been entrusted by Aaron Diamond to care for his estate, widow, and Foundation “spent a lot of 
time figuring out what their commissions were going to be,” explained McGee. As executors, 
they were entitled by law to two percent of the total estate, each. They also had the right to bill 
up to two percent in legal and accounting fees. “So it was clear that they were trying to figure out 
ways to bill up to every nickel that they might get. They were also going to be entitled to trustee 
fees from the marital trust, and later on, it turned out that they also thought they were going to 
get fees from the Foundation, just for serving as directors.”16  
 A series of struggles ensued over the next months. Mrs. Diamond, advised by Vincent 
McGee, sought legal assistance but resisted getting into a long legal battle. She made a 
settlement with the power and cash-hungry directors, trustees, and board members, forced 
another executor and trustee to resign, and sent a business manager of Aaron Diamond‟s 
company to jail after discovering the embezzlement of millions of dollars. 
 These years of turmoil had a major impact on Irene Diamond and the Foundation. “My 
husband had left eight million dollars to each of these people. And they immediately started 
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stealing. It was just incredible,” exclaimed Mrs. Diamond. “I learned a great deal. The hard way. 
I don‟t think I slept through a night in maybe three or four years.”17 To rid herself of the vultures, 
Mrs. Diamond spent nearly $20 million of her own resources in legal fees and payoffs.  
 “The struggle was terrible,” observed McGee, noting the anxiety, frustration, and sense of 
responsibility experienced by Mrs. Diamond. “It delayed us getting a real grants structure going, 
and it meant that she and I spent a lot of time trying to strategize and worrying with the lawyers 
about what was going on.” Looking to the positive, McGee added, “It built a very strong bond 
between Mrs. Diamond and me, which was the basis of our marvelous and strong working 
relationship.”18  
 
 
LAUNCH OF GRANTMAKING AT THE AARON DIAMOND FOUNDATION 
 
 ―Oh, it’s her vision and her husband’s vision. I think that those of us who are on the 
 board, she believes can contribute, and indeed, I feel as if we do. But it can never be 
 forgotten that it was essentially her idea and her husband’s idea, and we’re all in one 
 way or another focused on trying to make that a reality. And so she’s the fulcrum.‖19 
       —Foundation Board Member 
 
Upon reaching a settlement in May 1986, the Foundation finally began to receive its portion of 
the assets of Aaron Diamond‟s estate. A reconstituted board of directors clarified its governance 
structure and decision-making procedures, delineated the rights of the board, and extended 
certain grantmaking authorities to the president. Further, the board decided that no director 
would receive compensation for his or her service on the board. In a vote of confidence for 
Vincent McGee, the board authorized a three year agreement retaining his services as executive 
director. In December, the Aaron Diamond Foundation became one of the first foundations to 
adopt a socially responsible investment policy, which prevented investments in South Africa 
under apartheid, tobacco, gaming, the defense industry, and nuclear power.
20
 Finally, the board 
affirmed the Diamonds‟ desire to spend down the assets of the Foundation within ten years and 
set December 31, 1996, as the date of sunset. 
 Having resolved many of the structural and governance issues, the board turned its 
attention to articulating policies and making grants in the Foundation‟s three program areas 
while Vincent McGee oversaw the development of a lean staff structure and no-frills operating 
style. McGee instilled the same sense of openness and responsiveness that he had experienced at 
the DJB Foundation more than a decade before. McGee preferred to handle all proposals 
efficiently and to notify applicants promptly of the Foundation‟s decisions. He also advocated a 
hands-on approach to assisting grantees frame their plans, find employees and consultants when 
needed, connect with complementary efforts, and appeal to other potential donors. 
 To carry out the work of the Foundation at a modest overhead cost, McGee hired a small 
staff. This pleased Mrs. Diamond, who came to the office every day to oversee the work of 
McGee and his staff. “I didn‟t want a big staff,” she explained. “I would rather see the money go 
to the programs than the perks of huge offices and that sort of thing.”21  
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 McGee engaged several consultants on a part-time basis to advise the Foundation on its 
program areas, and to review and act upon proposals submitted to the Foundation. McGee 
supplemented this group with a full-time general program officer to assist in the review of 
proposals. In addition, McGee hired a handful of full- and part-time office staff, including a 
grants administrator, a secretary/receptionist, and an office manager/bookkeeper. At times of 
peak workload, McGee made limited use of temporary clerical staff.  
 The program staff and board members forged a productive partnership lacking in rigid 
formality. Staff members reviewed proposals and prepared recommendations for Mrs. Diamond 
and Vincent McGee to take to the board. The program advisors were on hand during board 
meetings to answer questions and present policy issues. Board discussions were lively, far 
reaching and meaningful. Although the board usually trusted the instincts of Mrs. Diamond and 
the staff, Mrs. Diamond and she encouraged healthy debate. She had little patience for “yes 
people.” 
 The planned demise of the Foundation had a significant impact on the grantmaking 
philosophy and operations of the Foundation. McGee noted that the staff and board had “the 
ability to look closely at a problem and not be distracted by worries about long-term job security 
or budding bureaucracy.”22 In addition, the short time horizon encouraged the Foundation to take 
calculated risks in hopes of achieving major impact. Never one to shrink from opportunity, Mrs. 
Diamond exclaimed, “This money is investment money. When Aaron would make an investment 
in property, he wasn‟t sure if it was going to be a success. If it wasn‟t a success, you attempted to 
bring in others or to redevelop it and change it and you moved on.”23 Applying this analogy to 
the philanthropic community, McGee commented, “I think that it‟s very important for private 
funders to take risks or make bets on people and groups in the community that want to start 
things up or get the first thing moving, and if you give modest support and try to find a couple of 
other people to join you, and then watch the growth of an organization over a year to two, you 
are not taking unreasonable risk.”24 
 As a result of these efforts to develop a lean staff structure, streamlined processes, and 
entrepreneurial and responsive culture, funds started flowing out of the Foundation‟s coffers and 
into the community at an increasing rate. The Foundation cast a broad net in each of its program 
areas, making short-term grants.
25
 In the fiscal year ending November 30, 1986, the Aaron 
Diamond Foundation made 84 grants totaling $3,051,726. The largest grant was $457,326, while 
the smallest was $200.
26
 By May 1987, the Foundation office was receiving forty to sixty 
telephone inquiries each day.
27
 The Foundation paid out $8,907,978 in grants that year.
28
 The 
Aaron Diamond Foundation had become the second-largest foundation focused solely on New 
York City and its residents, ranking behind only the New York Community Trust.
29
 
 
Initial Lack of Focus in the Medical Research Portfolio 
 By the end of 1987, the medical research portfolio had grown to $2,838,967, up from 
$1,080,826 in 1986. However, it had taken the Foundation more than two years to achieve a 
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coherent, focused program in this area. Since Mr. Diamond did not survive to provide specific 
guidance on his philanthropic intentions, the initial medical research grants were driven largely 
by the myriad interests of Irene Diamond. A staff member explained, “[Mrs. Diamond‟s] initial 
interest in cardiovascular research was related to the cause of her husband‟s death, cardiac 
arrhythmia. So she wanted to learn more about that. She also was concerned about cancer, so we 
did things on cancer. . . . And so we started off with her interests.”30  
 Another area that captured Mrs. Diamond‟s attention was AIDS; she closely followed 
newspaper reporting on the emerging epidemic. In one of her earliest conversations with Vincent 
McGee, Mrs. Diamond suggested, “You know, I think maybe we can make a difference in that 
field. Let‟s investigate it.”31 McGee had gained some experience in AIDS programming at the 
Hunt Alternatives Fund and he agreed that the area was promising. For McGee, the real question 
was, what could a foundation of this size, profile, and time limit do?  
 Mrs. Diamond and McGee raised this question with original board members at a meeting 
in July of 1985.
32
 The board members discussed the possibility of support for research in this 
field and agreed to seek advice from Dr. Lewis Thomas, a respected physician, biomedical 
researcher, and author who was widely recognized as the “dean of infectious diseases 
clinicians.”33 An acquaintance of Mrs. Diamond, Dr. Thomas had served as the dean of the 
medical schools of Yale University and New York University and as president of Memorial 
Sloan-Kettering Cancer Center in New York City. 
 With the counsel of Dr. Thomas, who was eventually invited to join the board of 
directors, Mrs. Diamond and Vincent McGee carefully considered the Foundation‟s strategic 
options in AIDS research and identified the most promising areas for involvement. According to 
McGee, “There appeared to be an opportunity for a modest private foundation to jumpstart basic 
and applied research in the face of lagging public support and institutional hesitancy to come to 
grips with an expanding epidemic of historic proportion. In 1985 and 1986, ignorance, fear and 
homophobia still blocked concentrated, clear and focused efforts to meet the [AIDS] crisis 
nationally. The larger international dimensions were only beginning to be understood.”34 
 In late 1985, the Foundation awarded one-time grants of $150,000 each to Dr. Alvin 
Friedman-Kien, to support antiviral treatment study of AIDS patients of at New York University, 
and to Dr. Bijan Safai, to develop an immunization program at Memorial Sloan-Kettering.
35
 
Because there were very few AIDS-related research efforts underway in New York City at that 
time, the Foundation soon thereafter made a rare exception to its geographic limitation. In early 
1986, Mrs. Diamond and Vincent McGee traveled to Boston to visit Dr. Max Essex and Dr. Bill 
Hazeltine and then made the Foundation‟s first major multiyear grants for AIDS research. 
 Despite these important grants, AIDS was not yet the highest medical research priority 
for the Foundation. Other early grants funded research into the cause and possible treatments for 
Alzheimer‟s disease, hypothermia and hyperthermia among the homeless, and lead poisoning in 
children. Without a sharp focus in its medical research portfolio, the Foundation risked diluting 
its funding and weakening its impact. 
 
A Chance Meeting Leads to an Important Decision 
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 While riding the Madison Avenue bus one day early in 1986, McGee bumped into a 
former colleague from his days at the City University of New York. A leading medical educator, 
Dr. Alfred Gellhorn helped to establish and served as the first dean of the medical schools at the 
University of Pennsylvania and at the City University of New York, introducing dimensions of 
social thinking into the curricula and operations at both institutions.
36
  
 On the bus, McGee described the Aaron Diamond Foundation and the board‟s efforts to 
focus the medical research portfolio. “Alfred, we need you!”37 insisted McGee. When Dr. 
Gellhorn came to meet Mrs. Diamond shortly afterward, it was clear that the two shared similar 
values. “There was an immediate meeting of minds. We asked him if he would give us a day a 
week consulting time,” explained McGee, noting that an agreement was reached quickly. “He 
was very helpful because he also had a maturity and ability to nudge [Mrs. Diamond] along in 
areas where she was reluctant in terms of staffing and structuring the Foundation, and thinking 
about different possibilities and ideas.”38 
 Sharing with Dr. Thomas the responsibility for reviewing the wide variety of medical 
research proposals the Foundation received, Dr. Gellhorn quickly recognized an opportunity to 
target the Foundation‟s funding. Confident that the search for effective methods of prevention 
and treatment of AIDS was one of the most important research areas in which the Foundation‟s 
modest funding could make a real difference, he explained to Mrs. Diamond that ongoing 
research efforts on cardiovascular disease and cancer were heavily funded by federal and 
philanthropic sources, while funding for research on AIDS was still scarce (see Exhibit 5). 
Gradually, Dr. Gellhorn was able to persuade Mrs. Diamond and the board to focus their grant 
making. “I told the board that [research on these other diseases] is what all of the other 
foundations are funding. Since this foundation is focusing on New York, shouldn‟t we concern 
ourselves with a couple of the most important issues facing the city—AIDS and drug abuse?”39 
 The board quickly achieved consensus. As Vincent McGee reported in the Foundation‟s 
annual report, “AIDS and the compromise of the immune system by HIV is a pressing public 
health problem for all New Yorkers, poor and affluent alike. . . . The principal means of 
controlling the AIDS epidemic will emerge from advances in viral molecular biology and basic 
immunology research.” 
 
 
NEW YORK CITY: EPICENTER OF THE AIDS EPIDEMIC 
 
 ―We are at the center of an epidemic in North America. It is a long, dark tunnel and we  
 don’t have any light at the end of it.‖ 
  —Health Commissioner Stephen Joseph, New York Times, January 17, 1987 
 
In June 1981, the Center for Disease Control reported the first 41 cases of a rare cancer among 
homosexual men. Soon known as Acquired Immune Deficiency Syndrome (AIDS), the strange 
new disease raised the specter of a plague before an American public that had assumed that, in 
the age of modern medicine, epidemics were part of the past. AIDS remained a puzzle to public 
health officials until investigators from New York‟s health department, working closely with 
CDC epidemiologists to interview infected individuals, discovered that the infection was 
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generally passed through sexual contact with an infected partner or sharing of contaminated 
hypodermic needles between intravenous drug users.
40
 Over the next several years, researchers 
identified the cause of AIDS—the human immunodeficiency virus (HIV)—and developed a test 
to detect the virus in asymptomatic individuals, though little was known about its basic 
molecular biology.  
 Advances in the medical understanding and treatment of the disease came too slowly for 
New Yorkers terrified by a rate of infection and death toll that surged during the mid 1980s. By 
June 1987, the city health department had registered more than 10,000 diagnosed cases of AIDS 
in New York, nearly a third of the country‟s total.41 Public health officials worried that the 
registered cases were just the tip of the iceberg. Estimates of the total number of individuals 
infected with HIV ran as high as 400,000.
42
 At particularly high risk were the city‟s 200,000 
intravenous drug users.
43
 AIDS had become the number one killer of New York men ages 25 to 
44 and women ages 25 to 29,
44
 and the fourth leading killer over all age groups.
45
 The 3,190 
deaths attributed to AIDS in New York in 1987 represented a 20% increase over the previous 
year.
46
 The health department projected that AIDS would claim 40,000 lives in New York by 
1991.
47
 Services related to AIDS cost the city $400 million in 1987; a panel of experts predicted 
that this figure could rise to $1 billion by 1991.
48
 
 Advances in public awareness and understanding came just as slowly as progress on 
detection and treatment of AIDS. In May and June of 1987, The Gallup Organization conducted 
a telephone poll of 1,015 New Yorkers over the age of 18 and found that four out of ten 
respondents were worried about contracting AIDS and that three out of four unmarried 
respondents claimed that they had changed their sexual habits in fear of the virus.
49
 Four in ten 
New Yorkers incorrectly believed that the AIDS virus could be contracted by donating blood.
50
 
Fearful of contracting the virus through casual public contact, seven in ten respondents favored 
requiring tests of restaurant food preparers and servers, and four of ten supported requiring tests 
of children entering public schools.
51
 
 Looking back upon this troubled time, New York City Commissioner of Health Stephen 
C. Joseph, M.D., wrote, “Those years saw both the full explosion of the epidemic and our 
gradual understanding of its nature. They were years of stridency and fear, sometimes of 
violence and terror, as the epidemic moved from its initial concentration among gay men to 
minority drug users of both sexes. Clashes of policy and politics about disease reporting and 
contact tracing, antibody testing, education of the public, distribution of needles and syringes to 
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drug addicts, and the estimates of the extent of the epidemic itself became daily and troubling 
arguments.”52 
 
A Health Commissioner Engages in Trench Warfare Against AIDS 
 Appointed by Mayor Edward I. Koch to the position of Commissioner of Health in 
March 1986, the outspoken Dr. Joseph was no stranger to public health controversies. A 
pediatrician with interests in clinical and policy aspects of healthcare in the U.S. and abroad, 
Joseph had served in numerous positions in the public and private sector, gaining respect for his 
integrity, openness, and down-to-earth style. As the highest-ranking medical professional in the 
U.S. Agency for International Development, Joseph resigned his position in 1981 to protest the 
Reagan administration‟s vote against a World Health Assembly proposal to limit inappropriate 
marketing of baby formula in developing counties. Calling the White House position “immoral 
and unprofessional,”53 Joseph argued that aggressive advertising endangered the health of infants 
by luring mothers away from breastfeeding. 
 In his debut news conference as commissioner, the bearded and telegenic Joseph declared 
that fighting AIDS would be his top priority. Battling public fears and misinformation on the 
AIDS crisis, the vocal health commissioner became a familiar face on the nightly news as he 
took an urgent message of prevention to the public. Steering clear of a “business as usual” 
mindset, the commissioner and his staff proposed a series of then-controversial measures, such 
as a needle exchange program for drug addicts, promoting AIDS education in public schools, and 
distributing free condoms through public clinics and hospitals. To the furor of his socially 
conservative critics, Joseph unveiled a major ad campaign promoting condom use in May 1987. 
Unfazed by a barrage of accusations and delighted by the resulting political firestorm, a smiling 
Commissioner Joseph explained, “The more controversy we have, the more we negotiate as a 
society what we want to do, and that‟s useful. Also, the more attention it gets to the ads, which is 
exactly what we want. So I hope we have plenty more conflict about it.”54  
 
Commissioner Joseph Receives a Call from Vincent McGee 
 Vincent McGee closely followed media reports on Commissioner Joseph‟s aggressive 
public health campaign and his struggle to gain widespread support. McGee decided to reach out 
to Joseph after the commissioner spoke at a monthly gathering of business executives and public 
officials. “There was a report in Newsday a day later that 25 corporate executives who had been 
at the breakfast were called by Newsday and not one of them would speak about AIDS for 
attribution. . . . I felt bad about Commissioner Joseph and I called him up and said, „Can we talk? 
Can we get to know each other?‟”55  
 Commissioner Joseph responded that he had never heard of the Aaron Diamond 
Foundation, but he was well aware of the renowned Dr. Thomas. McGee described the 
Foundation and its programmatic emphasis on medical research and explained that the only 
restrictions on the funds were that they had to be used on programs that would benefit New York 
City and that all funds had to be expended in ten years. Seeking an opportunity for collaboration, 
McGee offered to bring Mrs. Diamond and Dr. Thomas to meet with Joseph to discuss potential 
projects. Intrigued by the unsolicited offer of support, the commissioner agreed to a meeting. 
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 At first, Irene Diamond was reluctant to meet with the commissioner. She was averse to 
involving the Foundation in a partnership with the city, fearing endless red tape and bureaucratic 
hand-wringing. Gradually, McGee and Dr. Thomas convinced Mrs. Diamond to suspend her 
prejudgment and accompany them to sit down with the commissioner. 
 
 
PROPOSAL FOR A LANDMARK VENTURE 
 
On that Friday morning in October, McGee and Mrs. Diamond traveled together to the Health 
Department Building, a “boxy neo-Classical cum Art Deco cube”56 occupying an entire city 
block on the border between Chinatown and Little Italy. Ascending a short flight of steps flanked 
by a pair of massive stone lanterns crowned with eagles, McGee and Mrs. Diamond made their 
way into the marble lobby, where they found Dr. Lewis engaged in a conversation with an old 
colleague. After a brief exchange of pleasantries, the three took the elevator to the third-floor 
offices of the Commissioner of Health. Inside the commissioner‟s suite, the three were 
welcomed and ushered directly into Commissioner Joseph‟s cavernous office. Arising from 
behind his desk, Joseph warmly greeted the trio and asked them to join him at one end of a long 
conference table.  
 Prior to the meeting, Commissioner Joseph had given careful thought to what programs 
would appeal to Mrs. Diamond. He expected that Mrs. Diamond, an alumna of the motion 
picture industry, would have an interest in funding videotaped public service announcements 
(PSAs) to raise public awareness and understanding of AIDS and other public health issues. He 
explained to Mrs. Diamond that he was working with advertising giant Saatchi & Saatchi to 
develop the PSAs. “Basically, I trotted out my dog-and-pony show,” the commissioner later 
reflected. “My presuppositions had led me to present the program that I expected she might 
like.”57 Soon, however, Joseph sensed Mrs. Diamond‟s rising boredom. Before he had a chance 
to ask for her thoughts, Mrs. Diamond spoke up. 
 “You know, Dr. Joseph, that is all lovely and interesting. But what I am really interested 
in is research.”58 
 The commissioner glanced at McGee, who gave a barely perceptible nod. Looking back 
at Mrs. Diamond, Joseph cleared his throat, leaned back in his chair and, as he would later 
recount, “reached back into his hip pocket” to pull out an idea that had been germinating in his 
mind for some months.
59
 With no preparation, he began to pitch his concept for a landmark 
venture in the field of AIDS research. 
 “Well, Mrs. Diamond, let me share another idea. What we really need is a first-class 
AIDS research laboratory. We lack a highly secure, centralized research laboratory where we can 
greatly expand AIDS research efforts already underway in New York, both in the private and 
public sector,” explained Joseph, insisting, “The situation clearly needs correction.”  
 
Need for Basic Research into AIDS  
 Joseph explained that, shortly after assuming the post of health commissioner, he 
identified the need for a research effort to learn more about the basic science of AIDS and the 
HIV virus. While New York-based researchers had done much to advance the medical 
understanding of how HIV is spread, the city‟s research institutes had not made similar progress 
on exploring the basic biology of the virus. “There is a good deal of high quality research in 
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medical schools, but no cohesive, focused program for looking at AIDS from the perspective of 
biochemical research.”60  
 The commissioner pointed out that one obstacle to a successful research effort was the 
level of competition for funding among the existing research programs. He explained that New 
York University Medical Center and the NYU School of Medicine had offered to lead the effort, 
but Joseph was afraid that this could lead to turf wars with other local research institutes. Instead, 
the commissioner hoped to engage a critical mass of scientists and public health professionals 
from the private and public sectors in a cooperative, multidisciplinary effort that would transcend 
institutional boundaries and personal ambitions. 
 Another major barrier to a centralized research effort was a shortage of basic virological 
and immunological facilities, explained the commissioner. Not comfortable handling HIV in 
their own laboratories, researchers were forced to send their specimens outside of New York 
City to obtain more complex virologic and immunologic assays so necessary in their work. The 
commissioner explained that this effort would require special high-containment laboratory 
facilities of the type available only at the New York Blood Center, Memorial Sloan-Kettering 
Institute, Albert Einstein Medical Center, the Public Health Research Institute (PHRI), and 
perhaps one or two other institutions.
61
  
 Of these potential sites, Joseph held the greatest hope for establishing a new laboratory in 
space occupied by PHRI, a private research institute established by the city in 1942 to provide 
the Department of Health with direct access to the biomedical research community. Joseph was 
confident that PHRI could identify sufficient space in the Public Health Laboratories Building 
without serious disruption of existing programs, which was not the case at the major academic 
medical centers, whose facilities barely met the needs of ongoing research efforts. Moreover, 
PHRI was conveniently located close to Bellevue Hospital and the Manhattan Veterans 
Administration Hospital, both of which had very large populations of AIDS patients. 
 Answering questions from Dr. Thomas, the commissioner explained that the facility 
would likely require 15,000 to 20,000 square feet, including 3,000 to 4,000 square feet for the 
viral containment lab for safe handling and storage of the live virus. The facility would require 
sufficient space for microbiology, biochemistry, and other auxiliary laboratories, as well as 
meeting rooms and office space. With room for 40-50 researches, including its own staff and 
outside investigators, this would probably be the largest private research laboratory in the world 
devoted solely to AIDS. Joseph hoped that a cutting-edge research facility would not only lead to 
real progress in the struggle to understand AIDS, but it would also attract the very best 
researchers in the world.  
 
A Request for Support 
 The commissioner stated that the city could provide space at the Public Health Research 
Institute rent free for twenty years, along with $3.4 million for renovations. He estimated that the 
effort would require an additional $2 to $3 million, plus a little over $1 million in annual 
operating expenses, for a total of $5 to $6 million over the first three to four years. 
 Commissioner Joseph admitted that he had been looking for donors for this project for 
almost a year, but nobody was willing to take the lead on this. He explained that most of the 
foundations that he had spoken to were not interested in basic research; they were more likely to 
support programs in prevention and treatment. Joseph believed that if the Aaron Diamond 
Foundation would agree to play a lead role, other funders would be willing to step up and join 
the effort. 
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 “Mrs. Diamond, would the Aaron Diamond Foundation be willing to assemble and 
coordinate a group of ten to fifteen foundations to partner with the city in establishing a cutting-
edge AIDS research laboratory?” 
 Intrigued by the idea but dreading interminable negotiations, Mrs. Diamond responded, 
“Well, Dr. Joseph, that would be quite a challenge, indeed. Let us think about it. Vinny will get 
back to you.” 
 
 
A DECISION FOR THE AARON DIAMOND FOUNDATION 
 
While waiting for Mrs. Diamond‟s car after the meeting with the commissioner, Vincent McGee 
reflected on the commissioner‟s request to coordinate and fund a centralized, collaborative AIDS 
research effort. The Foundation‟s earlier grants had focused on building AIDS research efforts in 
existing institutions. He applauded the commissioner‟s call for a multidisciplinary, cross-sectoral 
approach and he believed that this would require the creation of an entirely new institution, free 
from the competition that characterized the existing players. McGee wondered how he could 
surmount Mrs. Diamond‟s trepidation over partnering with the city and collaborating with other 
foundations, an effort that would require patience of this strong-willed dynamo so unaccustomed 
to dragging her heels.  
 “Let‟s go, Vinny!” Mrs. Diamond interrupted McGee‟s reflection as the car pulled to the 
curb. McGee held the back door for Dr. Lewis and Mrs. Diamond and then took a seat in the 
front, directing the driver to take them uptown to the Foundation‟s offices in Rockefeller Center. 
As the car pulled away, the three sat quietly, taking in what had just transpired. 
 Was funding an AIDS research laboratory good fit for the Aaron Diamond Foundation? 
Should the Foundation attempt to convene a consortium of foundations or not? If so, what were 
the obstacles that had to be overcome? What were the opportunities and risks of the multiple-
foundation collaborative approach? Were there other strategies that the Foundation should 
consider? What size grant should the Foundation consider? 
 Mrs. Diamond was the first to break the silence. She leaned toward the front seat, tapped 
McGee on the shoulder and declared, “If we do this, it will take forever!”62 
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EXHIBIT 1 
 
 
Statement of Purpose of the Aaron Diamond Foundation, Inc. 
 
The purposes for which the corporation is to be formed are as follows:  
 
(a)  To acquire by bequest, devise, grant, gift, purchase, exchange, lease, transfer, 
judicial order or decree, or otherwise, for any of its objects and purposes as 
hereinafter set forth, any property—real, personal or mixed.  
 
(b)  Annually to use, apply, dispense, and distribute such part of the principal as the 
directors may determine, and all of the income of any funds or property that the 
corporation may from time to time possess, to such corporations, trusts or 
community chests, funds, or foundations, created or organized in the United 
States or in any possession thereof, or under the law of the United States or of any 
State or territory or of any possession of the United States, organized and operated 
exclusively for religious, charitable, scientific, literary or educational purposes, or 
for the prevention of cruelty to children or animals, no part of the net earnings of 
which inures to the benefit of any private shareholder or individual, and no 
substantial part of the activities of which is carrying on propaganda or otherwise 
attempting to influence legislation. 
 
 
 
Source: “Certificate of Incorporation of the Aaron Diamond Foundation, Inc.,” executed on 
December 13, 1955. 
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EXHIBIT 2 
 
 
Application Guidelines of the Aaron Diamond Foundation, Inc. 
 
The Aaron Diamond Foundation's grantmaking concentrates in New York City in three program 
areas: 
 
 Medical research: AIDS; drug abuse; immigrant health; young researchers. 
 Minority education: The improvement of the academic performance, educational 
achievement and resulting life opportunities of minority and disadvantaged students 
primarily in New York City's public school systems. 
 Culture: The arts, human rights and civil liberties. 
 
A letter of request should be accompanied by two copies of a short proposal giving a history of 
the project, outlining goals to be achieved, methods, budget and schedule for implementation. 
(Medical research applications should be in triplicate and include a short, non-academic 
description of the project, copies of relevant publications, and the vita of the principal 
investigator.) Please also include one copy of the applicant's most recent annual financial 
statement, a list of board members and current grants, and a copy of the current tax determination 
letter from the Internal Revenue Service certifying status as a public charity or the equivalent. 
 
The Foundation will respond to each applicant in writing and may request additional materials or 
a meeting. There are no deadlines for submission of requests. The Board of the Foundation meets 
regularly throughout the year. 
 
The Foundation does not intend to fund building programs, endowments, or other capital 
expenditures, to make grants to individuals or for production costs or to make loans. Grants will 
be made only to public charities as defined by the United States Internal Revenue Service. 
 
Initial contact should be addressed in writing to: 
 
Vincent McGee, Executive Director 
The Aaron Diamond Foundation 
1270 Avenue of the Americas, Suite 26XX 
New York, New York 10020 
(212) 757-XXXX 
 
 
 
Source: The Aaron Diamond Foundation, The Aaron Diamond Foundation Report 1986, 1987, 
 1988. p. 81. 
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EXHIBIT 3  
 
 
Aaron Diamond Foundation Grants for Medical Research, 1986-1987 
 
 1986 1987 
AIDS  
Basic Research 
 
  
Dana-Farber Cancer Institute 
44 Binney Street 
Boston, MA 02115 
Support for AIDS research on the role of glycoproteins in the course of the AIDS virus, William A. 
Haseltine, Ph.D., principal investigator. 
A major mystery of the AIDS virus is that although the human immune system develops antibodies to 
components of the virus coat, which is the basis for diagnosing the infection, these antibodies fail to destroy 
the virus or even inactivate it. This research at the Dana-Farber Cancer Institute is directed to a systematic 
and sophisticated identification of the components of the virus coat as a necessary step in vaccine 
development.  
 
  
 
 
 
$175,000 
Harvard School of Public Health 
Department of Cancer Biology 
665 Huntington Avenue 
Boston, MA 02115 
Support for an ongoing investigation into the development of a less virulent strain of the AIDS virus, for use 
as a potential "natural" vaccine, Myron Essex, D.V.M, Ph.D., principal investigator. 
The Foundation early in its biomedical research grant program identified Dr. Essex as a leader in the basic 
investigation of the AIDS virus and its close relatives. This confidence in Dr. Essex has been amply 
confirmed by the international recognition that his research has gained. Dr. Essex's research on a feline 
leukemia virus first identified the existence of a retrovirus critically important to an understanding of the 
Human Immunodeficiency Virus (HIV), which also proved to be a retrovirus. Dr. Essex's research is 
ultimately directed toward the development of a vaccine.  
 
 
 
 
 
 
$150,000  
 
 
 
 
 
$100,000 
Public Health Research Institute of the City of New York 
455 First Avenue 
New York, NY 10016 
Support for a study on bacterial systems with regard to implications for one AIDS virus, Karl Drlica, Ph.D., 
Ellen Murphy, Ph.D., Abraham Pinter, Ph.D., principal investigators. 
This research is directed to a fundamental aspect of the AIDS virus infection, namely, how does the virus 
become incorporated into the genetic databank, the chromosome. The putative protein of the AIDS virus 
involved in the insertion of the virus DNA into the host DNA has been described. These investigators at the 
Public Health Research Institute propose to obtain adequate quantities of this protein through genetic 
manipulation of a bacterial manufacturing plan, purify it and study its precise mechanism of action. The 
ultimate objective is to prevent the infection of the host by the virus.  
 
  
 
 
 
$175,000 
Rockefeller University 
1230 York Avenue 
New York, NY 10021-6399 
Support for a study on the immunobiology of AIDS, Zanvil Cohn, M.D., principal investigator. 
Dr. Cohn and his collaborators have made major contributions to the identification of the cells of the immune 
system and how they interact in the ultimate production of highly specific antibodies. In AIDS, long before 
the critical cells of the immune system are actually destroyed by the virus, their function is impaired. The 
research supported by the Foundation will investigate the complex mechanisms involved as a means of 
further understanding the disease process.  
 
  
 
 
 
$110,040 
Clinical Research 
 
  
Albert Einstein College of Medicine of Yeshiva University 
1300 Morris Park Avenue 
Bronx, NY 10461 
Support for a study on the transmission of the AIDS virus infection in pregnant women, newborns and 
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 1986 1987 
infants, Arye Rubinstein, M.D., principal investigator. 
The Pediatric Department at Einstein under Dr. Rubinstein's direction has a large number of children with 
AIDS. This extraordinary human and physical facility combines caring and nurturing attention to these 
victims of a lethal infection with sophisticated virological and immunological studies on the mechanism of 
transmission of the virus in pregnant women, newborns and infants. The study will investigate why not all 
babies born of women with the HIV infection develop the disease.  
 
$50,000  
 
$50,000  
 
Montefiore Medical Center 
11 East 210th Street 
Bronx, NY 10467 
Support for the study of infants born to AIDS- infected mothers, and intravenous drug users, both at high risk 
for developing the AIDS virus, to try to determine risk factors, Gerald Friedland, M.D., principal investigator. 
The AIDS clinic at Montefiore Hospital has a large population of IV drug abusers with a significant number 
of pregnant young women. The clinic's research is designed to learn about the transmission of the infection 
from the mother to her baby before or during birth. Thus far it has been found that babies born to mothers 
with a positive blood test for HIV also test positive, but a year later half of these babies have negative blood 
tests and are normal in their development. Dr. Friedland's earlier research into the epidemiology of AIDS 
among IV drug users helped show the importance of heterosexual transmission of the HIV infection from 
male addicts to their female partners. 
 
 
 
 
 
$125,000 
 
 
 
 
 
$125,000 
The New York Blood Center 
Kimball Research Institute 
310 East 67th Street 
New York, NY 10021 
Support for a unique several-year study of a group of men exposed to the AIDS virus early on in the 
epidemic, Cladd E. Stevens, M.D., principal investigator. 
The Foundation provided an interim grant to continue an epidemiological study of 850 homosexual men 
whose serum was obtained at intervals since 1979 for other purposes. Using this unique supply of blood from 
a high-risk population, it is now possible to examine these specimens for the presence of HIV antibodies and 
thus more precisely define the progress of the epidemic. 
 
 
 
 
 
 
$50,000 
 
New York University Medical Center 
550 First Avenue 
New York, NY 10016 
Support for a study of the AIDS transfer factor in immunotherapy, H. Sherwood Lawrence, M.D., principal 
investigator. 
Dr. Lawrence is a distinguished investigator of clinical problems related to the immune system. Many years 
ago he discovered a complex entity known as the "transfer factor," which could restore immune capacity to 
children with immunodeficiency diseases. Dr. Lawrence's research with AIDS patients suggests that this 
factor may inactivate the virus or interfere with its ability to be incorporated into the host genome.  
Support for a study on the impact of the AIDS virus on immunodeficiency in humans, Fred T. Valentine, 
M.D., principal investigator.  
The lymphocytes in patients with AIDS fail to make antibodies (similar to the problem in chronic lymphatic 
leukemia - see section on cancer, Long Island Jewish Medical Center). The research supported by the 
Foundation is directed at investigating the intimate mechanisms of antibody production in AIDS lymphocytes 
with the objective of overcoming the defect.  
 
  
 
 
 
$139,028  
 
 
 
 
 
 
 
 
$188,637  
 
SUB-TOTAL - AIDS $375,000 $1,062,705 
 
CANCER 
Basic Research 
 
  
Columbia University College of Physicians & Surgeons 
Comprehensive Cancer Center 
710 West 168th Street 
New York, NY 10032 
Support for an extensive research effort into oncogenes and other molecular markers in colon cancer, I. 
Bernard Weinstein, M.D., director. 
The Institute for Cancer Research at the College of Physicians & Surgeons has marshalled a multidisciplinary 
team of investigators to concentrate on cancer of the colon, which is second only to lung cancer in frequency 
in the U.S. The Foundation is supporting a portion of the comprehensive research program dealing with the 
basic mechanisms whereby normal cells lining the colon convert to cancer cells.  
 
  
 
 
 
 
$248,000 
Clinical Research   
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Long Island Jewish Medical Center 
Division of Hematology-Oncology 
New Hyde Park, NY 11042 
Support for a five-year trial of a variety of chemicals on chronic lymphocytic leukemia cells, in an effort to 
determine if arrested development can be overcome, Kanti Rai, M.D., principal investigator. 
Chronic lymphatic leukemia is, as the name implies, the excess production of lymphocytes which appear in 
the blood. Normal lymphocytes are of critical importance in the production of antibodies, but in chronic 
lymphatic leukemia the lymphocytes fail to fulfill this function. The Long Island Jewish Medical Center 
research is designed to determine why the blood cells do not produce antibodies with the ultimate objective of 
learning how to overcome the defect. 
 
  
 
 
 
$157,337 
Memorial Sloan-Kettering Cancer Center 
1275 York Avenue 
New York, NY 10021 
Support for the development of an effective vaccine against melanoma, based on research on the immune 
response of persons with the disease, Lloyd J. Old, M.D., principal investigator. 
Malignant melanoma of the skin can be a rapidly advancing, aggressive tumor that invades blood vessels as 
well as lymph channels and thereby metastasizes widely through the body. It also has long been known to 
elicit antibodies by the host immune system, and, in rare instances, these antibodies have slowed the progress 
of the disease. The team at the Memorial Sloan-Kettering Cancer Center proposes to identify the specific 
proteins in the melanoma tumor that stimulate the production of effective antibodies and ultimately utilize 
this knowledge to develop an anti-melanoma vaccine.  
 
  
 
 
 
$327,790 
SUB-TOTAL - CANCER $ 0 $733,127 
 
CARDIOVASCULAR DISEASE 
Basic Research 
 
  
Columbia University College of Physicians & Surgeons 
Department of Medicine 
630 West 168th Street 
New York, NY 10032 
Support for an investigation into the role of the lipoprotein in metabolism, working toward the prevention and 
cure of atherosclerosis, Arthur Magun, M.D., principal investigator. 
Dr. Magun is investigating the intimate pathways of complex molecules, including cholesterol, through the 
epithelium of the intestinal tract. This difficult research, if successful, will increase understanding of the 
dietary control of excess cholesterol absorption, which, in turn, will be important in the prevention of 
atherosclerosis. 
 
 
 
 
 
 
$40,000 
 
 
State University of New York at Stony Brook 
Department of Medicine 
Health Science Center 
Stony Brook, NY 11794-8160 
Support for a training center for young researchers in the cardiovascular field, as well as support for the work 
of more senior scientists engaged in research on cardiovascular disease, Robert Olson, M.D., Ph.D., director.  
(The Foundation began its support with a $50,000 grant in 1985.)  
 
 
 
 
 
 
$213,500  
 
 
 
 
 
 
$141,149 
SUB-TOTAL – CARDIOVASCULAR DISEASE $253,500 $141,149 
 
MISCELLANEOUS 
 
  
Bellevue Hospital Center 
Emergency Medical Services 
First Avenue and 27th Street 
New York, NY 10016 
Support for research concerning the pathogenesis and management of hypothermia and hyperthermia as seen 
in patients in the Bellevue Hospital emergency ward, Lewis Goldfrank, M.D., principal investigator. 
This project concerns the effects of extreme temperatures on the indigent and elderly population. Work to 
date has shown that patients with mild hypothermia comprise a separate clinical group from patients with 
severe hypothermia. Research calls for the development of a more accurate definition of the clinical picture 
for severe hypothermia, including sociologic, metabolic, and laboratory parameters. Research into 
hyperthermia risk factors will also be performed.  
 
  
 
 
 
 
$210,050  
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 1986 1987 
Columbia University College of Physicians & Surgeons 
Neurological Institute 
710 West 168th Street 
New York, NY 10032 
Support for the start-up phase of several projects on the basic biology of Alzheimer's disease, under the 
direction of Lewis Rowland, M.D. 
Drs. Joseph Herbert and Eric Schon have isolated the gene that leads to the production of the particular 
substance in the brain characteristic of Alzheimer's disease. A new and unexpected finding is that the gene in 
Alzheimer's patients leads to the production of an enzyme inhibitor of proteins, which characterize the 
pathological lesion of Alzheimer's. 
Drs. Norman Latov and Arthur Hays have been screening patients with Alzheimer's and other neurological 
diseases for the presence of autoantibodies that bind to neural tissue. They have found such autoantibodies, 
including ones that bind to the protein elements of the major pathological lesion of Alzheimer's. 
 
 
 
 
 
 
$427,326 
 
 
 
 
 
 
$302,340  
 
Montefiore Medical Center 
Lead Poisoning Prevention Project 
111 East 210th Street 
Bronx, NY 10467 
Ongoing support for this pioneering work on lead poisoning prevention, including community education, 
treatment and research, John Rosen, M.D., director. Lead poisoning, particularly of inner city children 
exposed to lead-laden fumes, lead-containing paint and other sources of lead, has consequences of serious 
proportions. (The Foundation's support for the Lead Poisoning Prevention Project began with a $25,000 
grant in 1985.) 
Special grant for the purchase of a mobile X-ray fluorescence unit. The multidisciplinary staff at Montefiore 
will assess the efficacy of medication in removing lead from the body. Since lead accumulates in bone, Dr. 
Rosen and colleagues have developed an X-ray fluorescence technique that assesses the deposit and the 
success of the drug in eliminating it.  
 
 
 
 
 
 
$25,000 
 
 
 
 
 
 
$25,000 
 
 
 
 
 
 
$129,500 
Public Health Research Institute of the City of New York 
455 First Avenue 
New York, NY 10016 
Support for research on the variability of genetic information in staphylococcus aureus, Richard P. Novick, 
M.D., principal investigator.  
"Staph" infections are frequent and serious in hospital populations. When penicillin was first introduced these 
infections were dramatically controlled but, with time, strains resistant to penicillin and other antibiotics have 
become a real threat. The present research is directed to understanding the mechanism of resistance and 
overcoming it.  
 
  
 
 
 
$235,096  
SUB-TOTAL - MISCELLANEOUS $452,326 $901,986 
   
TOTAL MEDICAL RESEARCH $1,080,826 $2,838,967 
 
 
 
Source: The Aaron Diamond Foundation, The Aaron Diamond Foundation Report 1986, 1987, 
 1988. pp. 11-20. 
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EXHIBIT 4 
 
 
The Aaron Diamond Foundation, Inc. Financial Statements for 1987 
 
 
 
Statements of Assets and Liabilities 
 
 
ASSETS 
 
December 31, 1987 
 
Cash and cash equivalents:  
Demand deposits $61,515  
Interest bearing deposits 18,534 
Money market funds:  
DBL Government Securities Fund 5,896,646 
Pierpont Taxable Fund 136,384 
Total 6,113,079 
Current receivables 109,567 
Investments:  
Marketable securities at fair value:  
Commercial paper (income tax basis-$27,727,475) 27,768,592 
U.S. Government and government agency obligations (income tax 
basis-$31,843,813) 32,253,575 
Fixed income securities (income tax basis-$24,462,523) 24,206,904 
Equity securities (income tax basis-$8,101,303) 7,454,750 
Dreyfus Index Fund (income tax basis-$2,032,690) 1,636,640 
12.25% mortgage receivable 7,500,000 
Notes and claims receivable 2,847,244 
Interests in real estate and real estate-related partnerships at adjusted Estate 
value 17,059,102 
Interests in affiliated corporations at income tax basis 920,990 
Property at 981 Third Avenue, New York City, office equipment and 
improvements (less accumulated depreciation) and other assets 325,930 
TOTAL $128,196,373  
  
LIABILITIES AND FUND BALANCE 
  
Liabilities:  
Due to stockbrokers $3,506,739  
Estimated amounts due in connection with sales of partnership interests 485,774 
Total liabilities 3,992,513 
  
Fund balance 124,203,860 
  
TOTAL $128,196,373  
 
 
 
 
Source: The Aaron Diamond Foundation, The Aaron Diamond Foundation Report 1986, 1987, 
 1988. p. 78. 
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Statements of Receipts, Income, Expenditures and Changes in Fund Balance 
 
 
 Year Ended Dec 31, 1987 
  
Receipts-distributions from the estate of Aaron Diamond  $5,434,037  
Income:  
Interest and dividends 9,068,694 
Net rental income-981 Third Avenue property 6,983 
Realized gains (losses) on sales of investments 530,485 
Distributive share of partnership (losses) (Note) (8,788,196) 
Increase (decrease) in net unrealized appreciation of securities (3,535,165) 
Total 2,716,838 
  
Expenditures:  
Grants paid 8,907,978 
Administration (including $893,000 of professional fees substantially 
in connection with receipt and administration of assets as a beneficiary 
of the estate of Aaron Diamond) 1,454,600 
Federal excise tax 295,709 
Total 10,658,287 
  
Excess of expenditures over receipts and income (7,941,449) 
  
Fund balance—January 1 132,145,309 
  
FUND BALANCE—December 31 $124,203,860  
  
 
 
(NOTE) Distributive Shares of Partnership (Losses): 
 
The Foundation's distributive share of partnership losses included approximately $8,400,000 representing the 
Foundation's share of both partnership depreciation and depreciation on the additional basis attributable to the death of 
Aaron Diamond. 
 
Cash distributions by the partnership to the Foundation totaled $1,641,000. Cash contributions to partnerships by the 
Foundation totaled $212,000. 
 
 
 
 
 
Source: The Aaron Diamond Foundation, The Aaron Diamond Foundation Report 1986, 1987, 
 1988. p. 79. 
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EXHIBIT 5 
 
 
New York Area Foundations Funding Medical Research and AIDS 
 
 
Foundation Assets 
Total Grant 
Expenditures 
# of 
Grants 
High Low Average FYE* 
Joseph Alexander 
Foundation 
 
$12,146,046 $538,500 63 $50,000 $1,000 n/a** 10/31/88 
Aaron Diamond 
Foundation 
 
$119,311,770 $18,625,812 255 $500,000 $500 $10,000-
$100,000 
12/31/88 
The Hearst 
Foundation, Inc. 
 
$117,832,000 $5,157,000 276 $100,000 $5,000 $10,000-
$25,000 
12/31/88 
William Randolph 
Hearst Foundation 
 
$259,556,000 $8,654,000 271 $1,000,000 $6,000 $15,000- 
$35,000 
12/31/88 
The Robert Wood 
Johnson Foundation 
(Princeton, NJ) 
 
$2,054,534,000 $87,552,000 n/a n/a n/a n/a 12/31/88 
Metropolitan Life 
Foundation 
 
$97,378,807 $7,169,456 840 $675,000 $100 $1,000-
$25,000 
12/31/88 
The Ambrose Monell 
Foundation 
 
$94,441,256 $3,688,500 104 $250,000 $1,000 $5,000-
$100,000 
12/31/86 
MONY 
 
$478,723 $380,145 84 $25,000 $25 n/a 12/31/87 
        
 
* ―FYE‖ = fiscal year ending (figures are based on one fiscal year for each foundation) 
 
** ―n/a‖ = not available 
 
 
Source: The Foundation Directory, 12th Edition, The Foundation Center, New York, 1989. 
 
 
NOTE: The 11th edition of The Foundation Directory
63
 lists only one foundation in the greater 
New York area with a declared programmatic emphasis on AIDS in 1985-1986: The Robert 
Wood Johnson Foundation in Princeton, New Jersey. The following edition, noted above, 
identified only 20 foundations with an emphasis on AIDS out of a total of 1219 foundations 
registered in state of New York. Of the 153 foundations that declared medical research as an 
emphasis, only 10 had a focus on AIDS; only 7 of these were located in the New York City area, 
listed above. 
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EXHIBIT 6 
 
 
Officers, Board, and Staff of the Aaron Diamond Foundation 
As of October 2, 1987 
 
Officers 
Irene Diamond, President 
Samuel Maitland, Vice President 
Peter Kimmelman, Treasurer 
Charles L. Mandelstam, Secretary 
Vincent McGee, Executive Director 
 
Directors  
Irene Diamond 
Peggy Dulany 
Manny Isidor  
Peter Kimmelman  
Samuel Maitland  
Charles L. Mandelstam  
Vincent McGee (ex officio) 
Jean Diamond Sargent 
Lewis Thomas 
 
Staff 
Vincent McGee, Executive Director 
Kate Chieco, Program Officer  
Ann Gael, Grant Administrator 
Elena Wong, Bookkeeper 
Isabella Dane, Assistant to the President and Executive Director 
Zenaida Isidro, Financial Officer 
Auristela Martinez, Support Staff 
Laurent Weichberger, Support Staff 
 
Advisors and Consultants 
Norm Fruchter, Minority Education 
Alfred Gellhorn, M.D., Medical Research 
Lewis Thomas, M.D., Medical Research 
 
 
Sources: The Aaron Diamond Foundation, The Aaron Diamond Foundation Report 1986, 1987, 
 1988; minutes of the board of directors, 1986-1987; Mariette J. Bates, An American 
 Phenomenon: A Qualitative Study of a Metropolitan Foundation with a Ten Year Life 
 Span, Dissertation, The Union Institute, 1995. 
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EXHIBIT 7 
 
 
Background Information on Vincent McGee, Executive Director 
 
With the exception of Mrs. Diamond herself, nobody had a greater influence on the Aaron 
Diamond Foundation than Vincent McGee, a social justice activist turned philanthropy 
professional. As is often the case for foundation executives, McGee came to the world of 
philanthropy through a serendipitous path.  
 As a young man, McGee left the Roman Catholic seminary in search of a broader 
experience. Working in a law firm to pay for tuition and living expenses, McGee enrolled in 
night classes at Hunter College of the City University of New York. After two years, McGee 
transferred to the University of Rochester, studying at night while working a day job as a quality 
control inspector at Kodak. McGee arrived in Rochester, New York just after the race riots of 
1964, a turbulent time. Meeting likeminded social activists and political operatives, McGee 
participated in the Johnson-Goldwater presidential election. He would later recount, “All of that 
was a kind of pressure cooker experience. The harsh reality of the workaday world at Kodak, 
studying fine art and ancient history and classical languages and history of religion and stuff in 
the day, as the Vietnam war heated up. Which led me to a decision to be a very active antiwar 
protester.”64  
 While attending the April 15, 1967 march from Central Park in New York to hear Dr. 
Martin Luther King Jr. speak at a rally near the United Nations, McGee publicly burned one half 
of his draft card and mailed the other half with a letter to President Johnson.  
 McGee graduated from Rochester and went to Union Theological Seminary to resume 
studies for the priesthood, but became more and more determined to stop the war. Soon McGee 
was arrested, tried, and convicted for conscientious objection to the Selective Service System 
and sentenced to a year in prison. During appeals up to the U.S. Supreme Court, he directed 
Business Executives Move for Vietnam Peace and New National Priorities, a group of 6,000 
business executives opposed to the war. In this role, McGee gained valuable experience as a go-
between with potential donors and projects.  
 Upon losing his appeal in the Supreme Court, McGee was sent to the minimum-security 
federal prison in Allenwood, Pennsylvania. McGee was adopted as a prisoner of conscience by 
Amnesty International and later appeared on President Nixon‟s infamous “Enemies List.”  
 As the director of the education program at Allenwood, McGee and his fellow volunteers 
provided inmates with classes in high school equivalency, English as a second language, 
remedial reading, and with confidential case work. McGee would later credit this experience for 
preparing for work in philanthropy. “Allenwood was the equivalent of a graduate degree in 
learning how things work. I couldn‟t take anything I‟d learned in the past for granted. The 
experience gave me a good context for work with nonprofits. One danger of foundation work is 
that people get arrogant and tell the grantees what they should be doing. Foundation people need 
to be good listeners. You need to keep reminding yourself that you‟re not the expert.”65  
 McGee was released in June of 1972 and was pardoned by President Gerald Ford on 
November 1, 1975. 
                                                 
64
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 Shortly after his release from prison, seeking to raise money for trip to Hanoi to bring 
back some prisoners of war, McGee contacted the widow of a wealthy stockbroker who had been 
active in the association of antiwar business executives. Carol Underwood Bernstein and her 
husband Daniel J. Bernstein were well known for funding progressive social change, political 
causes and other controversial areas often ignored by other foundations such as draft resisters, 
military deserters, prisoners and ex-convicts. The couple purchased full-page advertisements in 
The New York Times to protest the war in Vietnam.
 Upon Mr. Bernstein‟s death of leukemia in 
1970, his assets passed to the DJB Foundation, which he had created in 1948 to hold the assets of 
his father‟s estate. 66 Mrs. Bernstein continued to operate the foundation after Mr. Bernstein 
passed away. 
 In response to McGee‟s request, Mrs. Bernstein wrote a letter that summarized the 
challenge of effective philanthropy. “Dear Vinny: Here's a check for $3,000. I am glad to send it. 
There are three things about this money business: asking, saying „no,‟ or saying „yes.‟ The first 
two are hard, but the third is easy when the purpose is good and the funds are there."
67
  
 A short time later, Mrs. Bernstein married W.H. Ferry, a peace activist and social critic 
who had worked for several major foundations, including the Ford Foundation. The 
philanthropic couple hired McGee to work half time as the director of the DJB Foundation and to 
assist them in their personal giving. McGee‟s work with the Ferrys had a major influence on his 
career and on the eventual style of grantmaking and operations that he installed at the Aaron 
Diamond Foundation. “They provided for me an intensive period of learning public interest 
progressive philanthropy. They were responsive to the specific needs of people. So I learned with 
them a fair amount of principles of philanthropy. It was a streamlined operation. . . . If we 
decided, or they decided, they didn‟t want to do something, or it was out of their area of interest, 
a reject note or letter went out within a day or two of receipt of the material. . . . If a foundation 
grant needed to be made quickly, we‟d get [the other board members] on the telephone or send 
them the material, and make the grant within a week of receiving stuff. So there was a sense of 
responsibility about dealing with money as a trust and to be responsible to that public trust. You 
didn‟t take people for granted, you responded in a clear way. If you had questions, you make 
them succinct and didn‟t make people jump through hoops. And you didn‟t keep them 
waiting.”68  
 After helping the Ferrys spend down the assets of the DJB Foundation within four years, 
McGee held a variety of positions in the nonprofit sector. He worked as a fundraising for the 
American Civil Liberties Union, consulted to the New World Foundation, and assisted the 
President of CBS to organize a fundraising campaign for the Reporters‟ Committee for Freedom 
of the Press and to organize a more effective corporate philanthropy program at CBS. In 1977, 
McGee became the first nonacademic to serve as Vice President for Development and Planning 
at City College of the City University of New York (CUNY), where he oversaw the completion 
of a $25 million development campaign and built relations with many foundation executives.  
 In 1980, McGee met Helen and Swanee Hunt, daughters of the late H.L. Hunt, Texas 
businessman and oil tycoon. The sisters asked McGee to work with them half time to help them 
learn about philanthropy and to develop and implement a thoughtful giving program. Over the 
next five years, McGee helped launch and manage the Hunt Alternatives Fund, a family 
foundation focusing on community-based support for innovative social change projects in Dallas, 
Denver, and New York. McGee served as the first executive director of the foundation. 
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 The part-time arrangement with the Hunts allowed McGee to continue to pursue his 
interest in human rights advocacy. McGee volunteered extensively with several human rights 
and peace organizations, serving in several important positions, including chair of the board of 
directors of Amnesty International of the U.S.A. In the fall of 1984, a fellow Amnesty board 
member whose law firm represented the Aaron Diamond Foundation introduced McGee to a 
board member of the Foundation, who then invited McGee to meet Irene Diamond.  
 On November 6, 1984, Vincent McGee found himself at a board meeting of the Aaron 
Diamond Foundation to answer questions about his experience and about how he could advise 
the board. At the conclusion of the interview, the board members offered McGee a six-month, 
part-time contract to consult to board on the development of program policies and guidelines for 
the creation of an organizational plan, and to evaluate funding proposals received. Ready to scale 
back his involvement in the Hunt Alternatives Fund, which by that time had grown to a large and 
stable operation, McGee agreed to take on the challenge.
69
  
 Early in 1985, Vincent McGee was appointed full-time executive director of the Aaron 
Diamond Foundation and served until it finished its pay out at the end of 1996. 
 
 
 
Sources: Interviews with Vincent McGee, June 30, 2005 and February 2, 2006; Resume of 
 Vincent McGee, 2005; other sources as noted. 
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EXHIBIT 8 
 
 
Brief Description of Selected Board Members and Staff 
 
Peggy Dulany—Elected to the board in August 1986. Education expert and founder of The 
Synergos Institute. Born Margaret Dulany Rockefeller, Ms. Dulany stopped using her famous 
surname upon graduating from Radcliffe in the 1960s, her antiwar activist stance at odds with the 
politics of her father, David Rockefeller.
70
 Carrying on the family‟s philanthropic traditions, 
Dulany also served on the boards of the Rockefeller Foundation and Rockefeller Family Fund, 
Inc.  
 
Peter Kimmelman—Elected the board in May 1986 and became a trustee of Mrs. Diamond‟s 
marital trust. A financial advisor, Kimmelman had been a friend of Aaron Diamond, who was the 
very first client of Kimmelman‟s asset management firm.  
 
Dr. Lewis Thomas—Retained as a program advisor on medical research in November 1985 and 
elected to the board in c. 1986. Dr. Thomas was a renowned biomedical researcher, philosopher, 
and prize-winning author who combined scientific scholarship with clinical expertise.
71
 Born to a 
family physician father and nurse mother, Thomas entered Princeton at the age of fifteen and 
afterward attended Harvard Medical School. In a distinguished career of research, teaching, and 
administration, Dr. Thomas served as the dean of the medical schools of Yale University and 
New York University as well as president of Sloan-Kettering Institute. In 1982, Thomas was 
dubbed "the father of modern immunology and experimental pathology" at a symposium held in 
his honor.
72
 Dr. Thomas was best known to the public for his essays and poems published in a 
regular column in the New England Journal of Medicine from 1971 to 1980. He won a National 
Book Award for a collection of these essays, published in 1974 under the title The Lives of a 
Cell: Notes of a Biology Watcher.
73
  
 
Dr. Alfred Gellhorn—Retained as a program advisor on medical research in early 1986. A 
leading medical educator, Dr. Alfred Gellhorn helped to establish and served as the first dean of 
the medical schools at the University of Pennsylvania and at the City University of New York, 
introducing dimensions of social thinking into the curricula and operations at both institutions.
74
 
Deeply committed to minority education, Dr. Gellhorn had enlisted Vincent McGee‟s help at 
City University in early efforts to provide greater opportunities for young people interested in 
careers in medicine and science. Upon considering McGee‟s request to assist the Aaron Diamond 
Foundation after a chance meeting, Gellhorn agreed, on the condition that the foundation support 
his continuing high school enrichment program at City University, by that time known as the 
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“Gateway to Higher Education” program, whose board Gellhorn chaired.75 Dr. Gellhorn and his 
wife became close friends of Irene Diamond and he was later elected to the Foundation‟s board 
of directors.
76
 
 
 
Source: Mariette J. Bates, An American Phenomenon: A Qualitative Study of a Metropolitan 
 Foundation with a Ten Year Life Span, Dissertation, The Union Institute, 1995, (except 
 as noted). 
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